Clinical trial Recruiting at 8 sites Observational Ages 22 and up

Portable EMVision emu™ helmet for detecting brain bleeding in people with suspected stroke

Official title: Multi-Center, Prospective, Consecutive, Paired Diagnosis, Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

Run by EMVision Medical Devices Ltd · NCT06999122 · Data updated 2026-11-12

This project will test a portable helmet-like EMVision emu™ scanner that uses radio waves to detect bleeding in the brain in adults who come to the emergency department with suspected stroke.

More Stroke trials

Quick facts

Study typeObservational
Ages22 Years and up
SexAll
Enrollment300 (estimated)
SponsorEMVision Medical Devices Ltd
Research network
Locations8 sites (Los Angeles, California and 7 other locations)
StatusRecruiting
StartedMarch 26, 2025
Main results expectedNovember 1, 2026
Study endsNovember 28, 2026
Registry record updatedJuly 27, 2026
Trial IDNCT06999122 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 22 or older who present to a participating emergency department within 12 hours of stroke symptom onset with suspected stroke, whose head fits the device and who can undergo CT or MRI without delaying care are ideal candidates.

Probably not a fit

Patients who received acute stroke treatment before initial imaging, those with contraindications to neuroimaging, implanted head/neck electrostimulation devices or cranial metallic implants, or whose head does not fit the scanner are unlikely to receive benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational paired diagnostic accuracy effort comparing the EMVision emu™ helmet scanner to standard multi-modal CT and/or MRI imaging in adults with suspected stroke. Eligible patients are adults (≥22 years) presenting to participating emergency departments within 12 hours of symptom onset whose head size fits the device and where using the device will not delay care. Each participant receives the site’s standard CT/MRI workup while also undergoing the emu™ scan so results can be compared directly. The protocol ensures the investigational scan occurs in parallel with routine care and does not alter or delay standard treatment decisions.

Why it matters

Potential benefit: If accurate, the emu™ device could enable faster and more widely available detection of intracranial hemorrhage, supporting quicker treatment decisions and potentially better outcomes.

How similar studies have gone: Early pilot and small diagnostic studies of radiofrequency-based head scanners have shown promising results but larger multi-center accuracy data remain limited and this device approach is still relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults ≥22 years of age
2. Observable acute neurological deficit suspected to be stroke and within 24 hours of symptom onset
3. The use of the EMVision emu™ Brain Scanner will not delay the treatment of the patient
4. CT or MRI brain imaging following clinical evaluation per standard of care
5. Head size deemed suitable for scanning with the EMVision emu™ Brain Scanner -

Exclusion Criteria:

1. Has received treatment for current (suspected) stroke event prior to initial CT/MRI scan OR EMVision emu™ Brain Scanner scan (such as thrombolysis)
2. In-patient for a neurological condition prior to suspected stroke onset
3. In-patient in intensive care unit prior to suspected stroke onset
4. Contraindication to neuroimaging, such as a contrast allergy or other condition that prohibits CT, MRI and/or angiography
5. Presence of any implanted electro-stimulating devices in the head and neck
6. Presence of any metallic implants in the cranial vault or surrounding bones/tissue (Note that metallic objects distant from the scan area, such as dental implants, nasal piercing etc., are acceptable)
7. Presence of an intracranial pressure monitor or any other similar sensor that may compromise the placement of the investigational device
8. Inability to wear the investigational device (skin lesions on scalp, obvious recent blunt or penetrating injury to head, previous intracranial surgeries, neck injury etc.)
9. Unable to lie still for the duration of the scan
10. Pregnant or breastfeeding
11. Any other condition or symptoms preventing the participant from entering the study, according to the investigator´s judgment -

Where it's running

  • UCLA
    Los Angeles, California, United States
    Recruiting
  • Mayo Jacksonville
    Jacksonville, Florida, United States
    Recruiting
  • Mount Sinai West
    New York, New York, United States
    Recruiting
  • Mount Sinai Health System
    New York, New York, United States
    Recruiting
  • Memorial Hermann Memorial City Medical Center
    Houston, Texas, United States
    Recruiting
  • UTHealth
    Houston, Texas, United States
    Recruiting
Show 2 more locations
  • Liverpool Hospital
    Liverpool, New South Wales, Australia
    Recruiting
  • Royal Melbourne Hospital
    Parkville, Victoria, Australia
    Recruiting

Study contacts

  • Principal investigator: Reade De Leacy, MBBS(Hons) FRANZCR — Associate Professor of Neurosurgery and Radiology Director of Neurointerventional Spine Site Director Cerebrovascular Services Mount Sinai Queens Co-director Neuroendovascular Surgery Fellowship Department of Neurosurgery Mount Sinai Health System
  • Study coordinator: Christian Wight, PhD
  • Email: cwight@emvision.com.au
  • Phone: 61 (0) 490 109 797

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Remotely Delivered Step Count Rehab After Stroke

    This study tests a remotely guided program that uses step counting and six clinician sessions to see if people who had a stroke can feasibly use it at home.

    Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07649135

  • Best Care for Acute Stroke in General Wards

    A nurse-led program called BEST CARE ICTUS_HC is tested in hospitals without Stroke Units to see if it reduces stroke complications and helps recovery after an acute ischemic or hemorrhagic stroke.

    Recruiting University of Malaga · Antequera, Málaga and 3 other locations · NCT07627399

  • Deep phenotyping to explore recovery in young adults after stroke

    This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

    Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

  • Stem cell therapy for chronic stroke recovery

    This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.

    Recruiting Phase 2 Hokkaido University Hospital · Sapporo, Hokkaido · NCT06752720

  • Registry connecting stroke survivors with research opportunities

    This study connects stroke survivors with research opportunities to help find new treatments that can improve their recovery.

    Recruiting University of California, San Francisco · San Francisco, California · NCT03318432

  • Registry of stroke cases in Brest

    This study is collecting information on stroke cases in Brest to see how common strokes are, understand their impact on patients, and find better ways to treat them.

    Recruiting University Hospital, Brest · Brest · NCT02900521

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.